284 related articles for article (PubMed ID: 17723299)
41. Synthesis and SAR studies of very potent imidazopyridine antiprotozoal agents.
Biftu T; Feng D; Fisher M; Liang GB; Qian X; Scribner A; Dennis R; Lee S; Liberator PA; Brown C; Gurnett A; Leavitt PS; Thompson D; Mathew J; Misura A; Samaras S; Tamas T; Sina JF; McNulty KA; McKnight CG; Schmatz DM; Wyvratt M
Bioorg Med Chem Lett; 2006 May; 16(9):2479-83. PubMed ID: 16464591
[TBL] [Abstract][Full Text] [Related]
42. Synthesis and evaluation of gastroprotective and antiulcer activity of some 2-substituted-1H-imidazo[4,5-b] pyridines and -1H-benzimidazoles.
Loriga M; Paglietti G; Piras S; Sparatore F; Anania V; Demontis MP; Varoni MV; Fattaccio MC
Farmaco; 1992 Mar; 47(3):287-303. PubMed ID: 1503593
[TBL] [Abstract][Full Text] [Related]
43. (1H-imidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-ylamine derivatives: a novel class of potent MSK-1-inhibitors.
Bamford MJ; Alberti MJ; Bailey N; Davies S; Dean DK; Gaiba A; Garland S; Harling JD; Jung DK; Panchal TA; Parr CA; Steadman JG; Takle AK; Townsend JT; Wilson DM; Witherington J
Bioorg Med Chem Lett; 2005 Jul; 15(14):3402-6. PubMed ID: 15950465
[TBL] [Abstract][Full Text] [Related]
44. Antiviral 2,5-disubstituted imidazo[4,5-c]pyridines: from anti-pestivirus to anti-hepatitis C virus activity.
Puerstinger G; Paeshuyse J; De Clercq E; Neyts J
Bioorg Med Chem Lett; 2007 Jan; 17(2):390-3. PubMed ID: 17084081
[TBL] [Abstract][Full Text] [Related]
45. (1H-imidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-ylamine derivatives: further optimisation as highly potent and selective MSK-1-inhibitors.
Bamford MJ; Bailey N; Davies S; Dean DK; Francis L; Panchal TA; Parr CA; Sehmi S; Steadman JG; Takle AK; Townsend JT; Wilson DM
Bioorg Med Chem Lett; 2005 Jul; 15(14):3407-11. PubMed ID: 15955699
[TBL] [Abstract][Full Text] [Related]
46. Inhibition of gastric H+, K(+)-ATPase activity by compounds from medicinal plants.
Freitas CS; Baggio CH; Mayer B; dos Santos AC; Twardowschy A; Santos CA; Marques MC
Nat Prod Commun; 2011 Sep; 6(9):1253-4. PubMed ID: 21941891
[TBL] [Abstract][Full Text] [Related]
47. Structure-activity relationships of unsaturated long chain fatty acids in relation to the inhibition of gastric H+,K(+)-ATPase.
Murakami S; Muramatsu M; Araki H; Otomo S
Res Commun Mol Pathol Pharmacol; 1994 Jul; 85(1):57-66. PubMed ID: 7953195
[TBL] [Abstract][Full Text] [Related]
48. Inhibition of H+/K+ ATPase in the gastroprotective effect of Baccharis illinita DC.
Freitas CS; Baggio CH; Finau J; Anginoni M; Pizzolatti MG; Santos AR; Marques MC
J Pharm Pharmacol; 2008 Aug; 60(8):1105-10. PubMed ID: 18644203
[TBL] [Abstract][Full Text] [Related]
49. Reversible inhibitors of the gastric (H+/K+)-ATPase. 3. 3-substituted-4-(phenylamino)quinolines.
Ife RJ; Brown TH; Keeling DJ; Leach CA; Meeson ML; Parsons ME; Reavill DR; Theobald CJ; Wiggall KJ
J Med Chem; 1992 Sep; 35(18):3413-22. PubMed ID: 1326634
[TBL] [Abstract][Full Text] [Related]
50. 2,4,6-Trisubstituted pyridines: Synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship.
Basnet A; Thapa P; Karki R; Na Y; Jahng Y; Jeong BS; Jeong TC; Lee CS; Lee ES
Bioorg Med Chem; 2007 Jul; 15(13):4351-9. PubMed ID: 17493824
[TBL] [Abstract][Full Text] [Related]
51. Inhibition of gastric H+/K+-ATPase by substituted imidazo[1,2-a]pyridines.
Briving C; Andersson BM; Nordberg P; Wallmark B
Biochim Biophys Acta; 1988 Dec; 946(2):185-92. PubMed ID: 2850003
[TBL] [Abstract][Full Text] [Related]
52. Ligand docking in the gastric H+/K+-ATPase: homology modeling of reversible inhibitor binding sites.
Kim CG; Watts JA; Watts A
J Med Chem; 2005 Nov; 48(23):7145-52. PubMed ID: 16279772
[TBL] [Abstract][Full Text] [Related]
53. Nicotinamide derivatives as a new class of gastric (H+/K+)-ATPase inhibitors. III. Synthesis and gastric antisecretory activity of 2-[(2- and 4-aminobenzyl, and alpha-methylbenzyl)sulfinyl]-N-(4-pyridinyl) -3-pyridinecarboxamides.
Terauchi H; Tanitame A; Tada K; Nakamura K; Seto Y; Nishikawa Y
Chem Pharm Bull (Tokyo); 1997 Jul; 45(7):1177-82. PubMed ID: 9246752
[TBL] [Abstract][Full Text] [Related]
54. Research on heterocyclic compounds. XV. Substitution influence on the pharmacological activity in a series of imidazo[1,2-a]pyridines.
Abignente E; Arena F; Avara P; Biniecka M; Luraschi E; Marmo E; Cazzola M; Filippelli W
Farmaco Sci; 1983 Dec; 38(12):911-28. PubMed ID: 6607848
[TBL] [Abstract][Full Text] [Related]
55. The cavity structure for docking the K(+)-competitive inhibitors in the gastric proton pump.
Asano S; Yoshida A; Yashiro H; Kobayashi Y; Morisato A; Ogawa H; Takeguchi N; Morii M
J Biol Chem; 2004 Apr; 279(14):13968-75. PubMed ID: 14699149
[TBL] [Abstract][Full Text] [Related]
56. Inhibition of P-type ATPases by [(dihydroindenyl)oxy]acetic acid (DIOA), a K+ -Cl- cotransporter inhibitor.
Fujii T; Ohira Y; Itomi Y; Takahashi Y; Asano S; Morii M; Takeguchi N; Sakai H
Eur J Pharmacol; 2007 Apr; 560(2-3):123-6. PubMed ID: 17303113
[TBL] [Abstract][Full Text] [Related]
57. Synthesis and c-Src inhibitory activity of imidazo[1,5-a]pyrazine derivatives as an agent for treatment of acute ischemic stroke.
Mukaiyama H; Nishimura T; Kobayashi S; Ozawa T; Kamada N; Komatsu Y; Kikuchi S; Oonota H; Kusama H
Bioorg Med Chem; 2007 Jan; 15(2):868-85. PubMed ID: 17095233
[TBL] [Abstract][Full Text] [Related]
58. Spiro(imidazo[1,2-a]pyrano[2,3-c]pyridine-9-indenes) as inhibitors of gastric acid secretion.
Palmer AM; Chrismann S; Münch G; Brehm C; Zimmermann PJ; Buhr W; Senn-Bilfinger J; Feth MP; Simon WA
Bioorg Med Chem; 2009 Jan; 17(1):368-84. PubMed ID: 19026549
[TBL] [Abstract][Full Text] [Related]
59. Structure-activity relationship studies of 4-substituted-2-guanidinothiazoles: reversible inhibitors of gastric (H+/K+)-ATPase.
Ojha TN; Singh P; Sharma RC
Indian J Biochem Biophys; 1993 Aug; 30(4):239-43. PubMed ID: 8276427
[TBL] [Abstract][Full Text] [Related]
60. Aminoimidazo[1,2-a]pyridines as a new structural class of cyclin-dependent kinase inhibitors. Part 1: Design, synthesis, and biological evaluation.
Jaramillo C; de Diego JE; Hamdouchi C; Collins E; Keyser H; Sánchez-Martínez C; del Prado M; Norman B; Brooks HB; Watkins SA; Spencer CD; Dempsey JA; Anderson BD; Campbell RM; Leggett T; Patel B; Schultz RM; Espinosa J; Vieth M; Zhang F; Timm DE
Bioorg Med Chem Lett; 2004 Dec; 14(24):6095-9. PubMed ID: 15546737
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
